Product and Service [Axis] Biotech Retail Sales [Member] Equity Components [Axis] Common Stock [Member] Preferred Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Parent [Member] Noncontrolling Interest [Member] Consolidated Entities [Axis] Subsidiaries [Member] Revision of Prior Period [Axis] Previously Reported [Member] Location, Statement of Income, Balance [Axis] Business Combination [Axis] DSS Pure Air INC [Member] Asset Class [Axis] Accounts Receivable [Member] Intangible Asset, Finite-Lived, Class [Axis] Intellectual Property [Member] Ownership [Axis] Global BioMedical Inc. [Member] Global BioLife Inc. [Member] BioLife Sugar Inc [Member] Happy Sugar Inc [Member] Sweet Sense Inc. [Member] Global Sugar Solutions Inc. [Member] Impact Biolife Science Inc [Member] DSS Biomedical International Inc [Member] DSS Biolife International Inc [Member] Measurement Frequency [Axis] Fair Value, Recurring [Member] Cash and Cash Equivalents [Axis] Cash [Member] Developed Technology Rights [Member] Acquired Assets [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Class of Stock [Axis] Series A Preferred Stock [Member] Title and Position [Axis] Employees Directors and Consultants [Member] Certain Officers, Directors and Consultants [Member] Related and Nonrelated Parties [Axis] DSS Inc [Member] Debt Instrument [Axis] Revolving Promissory Note [Member] Liability Component [Member] Related Party [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Royalty Agreement [Member] Legal Entity [Axis] Chemia Corporation [Member] License Agreement [Member] Employment Agreement [Member] Award Type [Axis] First Year of Employment Term [Member] Second Year of Employment Term [Member] Third Year of Employment Term [Member] Mr Heuszel [Member] Two Mr Heuszel [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Entity Listing, Par Value Per Share Statement of Financial Position [Abstract] ASSETS Current assets: Cash Accounts receivable Inventory Current portion of notes receivable Prepaid expenses and other current assets Total current assets Other intangible assets, net Total assets LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable Accrued expenses Due to related party Total current liabilities Deferred tax liability, net Total liabilities Commitments and contingencies (Note 9) Stockholders’ equity Preferred stock, $0.001 par value; 100,000,000 shares authorized, zero shares issued and outstanding (zero on December 31, 2025) Common stock, $0.001 par value; 4,000,000,000 shares authorized, 107,821,231 shares issued and outstanding (104,621,231 on December 31, 2025) Additional paid-in capital Accumulated deficit Total stockholders’ equity of the Company Non-controlling interest in subsidiaries Total stockholders’ equity Total liabilities and stockholders’ equity Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Statement [Table] Statement [Line Items] Revenue: Total revenue Costs and expenses: Cost of revenue Sales, general and administrative compensation (inclusive of stock-based compensation) Sales and marketing Professional Fees Research and development Depreciation and Amortization Rent and utilities Other operating expenses Total costs and expenses Operating loss Other income (expense): Interest income Change in fair value of note payable, related party Interest expense Loss from operations before income taxes Income tax benefit Net loss Loss (income) from operations attributed to noncontrolling interest Net loss attributable to common stockholders Loss per common share: Basic Diluted Shares used in computing loss per common share: Basic Diluted Balance Balance, shares Acquisition of DSS PureAir, Inc. assets Acquisition of DSS PureAir, Inc. assets, shares Stock based payments for professional services rendered Stock based payments for professional services rendered, shares Stock based payments Net income (loss) Stock based compensation Stock based payments, shares Balance Balance, shares Statement of Cash Flows [Abstract] Cash flows from operating activities: Net loss from operations Adjustments to reconcile loss from operations to net cash used by operating activities: Depreciation and amortization Stock based compensation Stock based payment for professional services received Accrued interest on notes payable, related party Change in fair value of note payable, related party Decrease (increase) in assets: Accounts receivable Inventory Prepaid expenses and other current assets Increase (decrease) in liabilities: Accounts payable Accrued expenses Due to related party Net cash provided (used) by operating activities Cash flows from investing activities: Payments received on notes receivable Net cash provided by investing activities Net increase (decrease) in cash Cash at beginning of period Cash at end of period Organization, Consolidation and Presentation of Financial Statements [Abstract] Nature of Operations and Basis of Presentation Accounting Policies [Abstract] Summary of Significant Accounting and Reporting Policies Inventory Disclosure [Abstract] Inventory Receivables [Abstract] Notes Receivable Investments, All Other Investments [Abstract] Financial Instruments Intangible Asset, Goodwill and Other [Abstract] Intangible Assets Equity [Abstract] Stockholders’ Equity Related Party Transactions [Abstract] Related Party Transactions Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Supplemental Cash Flow Elements [Abstract] Supplemental Cash Flow Information Subsequent Events [Abstract] Subsequent Events Basis of Presentation and Principles of Consolidation Use of estimates Reclassifications Revision of prior period financial statements Loss per Share Fair Value of Financial Instruments Cash and cash equivalents Accounts receivable Notes receivable, unearned interest, and related recognition Inventory Intangible Assets Recoverability of Long-Lived Assets Due to related party Revenue Recognition Share-Based Payments Research and Development Provision for Credit Losses Acquisitions Continuing Operations and Going Concern Recent Accounting Standards Schedule of Condensed Financial Statements Schedule of Inventory Schedule of Cash, Cash Equivalents, Restricted Cash, and Note Payable, Related Party by Significant Investment Schedule of Intangible Assets Schedule of Future Amortization of Developed Technologies Schedule of Supplemental Cash Flows of Noncash Investing and Financing Activities Entity incorporation state country code Entity incorporation date of incorporation AccountingPolicyTextBlockTable [Table] Common stock, voting rights Noncontrolling interest Research and development Additional paid in capital Stock based compensation expense Acquisition value Acquisition shares Prepaid assets Assets acquired gross Premium paid for assets acquired Accounted for accordance amount CondensedFinancialStatementsTable [Table] State or other jurisdiction of incorporation or organization Date of incorporation or formation Attributable interest percentage Finished Goods Less allowance for obsolescence Inventory, net Notes receivable Interest rate percentage Debt maturity date Fair Value, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Adjusted cost Unrealized Gain/(Loss) Fair Value Cash and Cash Equivalents Intangible Asset, Finite-Lived [Table] Intangible Asset, Finite-Lived [Line Items] Useful life Gross carrying amount Accumulated amortization Net carrying amount 2026 2027 2028 2029 2030 thereafter Amortization expense Stock, Class of Stock [Table] Class of Stock [Line Items] Convertible shares Conversion basis Conversion of shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Share Price Shares granted Fair value of compensation Stock based compensation Shares issued Coomon stock issued Related Party Transaction [Table] Related Party Transaction [Line Items] Related costs for employees Debt Instrument, Interest Rate, Stated Percentage Debt Instrument, Maturity Date Debt Instrument, Periodic Payment Outstanding principal and interest Change in fair value of note payable related party Notes payable current Debt Conversion, Converted Instrument, Shares Issued Change in fair value Paid shares of common stock Shares paid of common stock Voting shares, percentage Loss Contingencies [Table] Loss Contingencies [Line Items] Royalty percentage Sale of royalty percentage Reimbursement or royalty Development cost, percent Development costs Liability Bonuses Shares issued in lieu of cash as payment for legal services Shares issued for acquisition of DSS PureAir assets Rent and utilities. Change in fair value of note payable related party.. Accrued interest on notes payable. State or other jurisdiction of incorporation or organization. Global BioMedical Inc. [Member] Global BioLife Inc. [Member] BioLife Sugar Inc [Member] Happy Sugar Inc [Member] Sweet Sense Inc. [Member] Global Sugar Solutions Inc. [Member] Impact Biolife Science Inc [Member] DSS Biomedical International Inc [Member] DSS Biolife International Inc [Member] Notes Receivable Unearned Interest and Related Recognition Policy [Policy Text Block] Recoverability Of Long Lived Assets [Policy Text Block] Due To Related Party [Policy Text Block] Continuing Operations and Going Concern [Policy Text Block] DSS Pure Air INC [Member] Premium paid for assets acquired. Acquired Assets [Member] Employees Directors and Consultants [Member] Certain Officers, Directors and Consultants [Member] Fair value of stock based compensation. DSS Inc [Member] Revolving Promissory Note [Member] Liability Component [Member] Royalty percentage. Royalty Agreement [Member] Chemia Corporation [Member] Sale of royalty percentage. Reimbursement or royalty paid. License Agreement [Member] Development cost percent. Employment Agreement [Member] First Year of Employment Term [Member] Second Year of Employment Term [Member] Third Year of Employment Term [Member] Mr Heuszel [Member] Two Mr Heuszel [Member] Shares issued in lieu of cash as payment for legal services. Shares issued for acquisition of assets. Biotech Retail Sales [Member] Due to related party Increase decrease in due to related party. Professional Fees [Member] Prior period reclassification of financial statements. Research and development expense of services. Assets, Current Assets Liabilities, Current Equity, Attributable to Parent Equity, Including Portion Attributable to Noncontrolling Interest Liabilities and Equity Operating Costs and Expenses Operating Income (Loss) Interest Expense, Nonoperating Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Income Tax Expense (Benefit) Net Income (Loss) Attributable to Noncontrolling Interest Net Income (Loss) Attributable to Parent Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Diluted, Adjustment Shares, Outstanding Share-Based Payment Arrangement, Noncash Expense Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable Increase (Decrease) in Accrued Liabilities IncreaseDecreaseInDueToRelatedParty Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Inventory Disclosure [Text Block] Accounts Receivable [Policy Text Block] Inventory, Policy [Policy Text Block] Intangible Assets, Finite-Lived, Policy [Policy Text Block] Due To Related Party [Policy Text Block] ResearchAndDevelopmentExpenseOfServices